Skip to main content
Product Comparisons4 min readUpdated Jun 2, 2026

q.e.d Science Review 2026: Strong on Claim Logic, More Nuanced on Data Rights

q.e.d is one of the more differentiated AI tools in this space because it focuses on claim structure and evidence logic, but its manuscript-rights language deserves close reading.

Author contextSenior Researcher, Oncology & Cell Biology. Experience with Nature Medicine, Cancer Cell, Journal of Clinical Oncology.View profile

Readiness scan

Find out what this manuscript actually needs before you pay for a larger service.

Run the Free Readiness Scan to see whether the real issue is scientific readiness, journal fit, figures, citations, or language support before you buy editing or expert review.

Diagnose my paperAnthropic Privacy Partner. Zero-retention manuscript processing.See example reports

Quick answer: q.e.d Science (verified 2026-05-14) is "Critical Thinking AI" with claim-tree decomposition, gap identification, and comparative scoring against hundreds of similar papers. Their explicit limit per their own page: "qed assumes that the data and results are genuine. Its current purpose is not to investigate fraud but to analyze, validate, and interpret the scientific reasoning and evidence presented." If your paper's main risk is inferential overreach, q.e.d is genuinely useful.

If the question is whether the science survives editor and peer review at the target journal, Manusights at $39 gives you the kind of feedback an experienced reviewer in your field would write: novelty against the live literature, journal-fit reasoning, and the specific experiments and reviewer objections that decide the outcome.

Run the free Manusights scan in 1-2 minutes, no card required.

Method note: This page was refreshed on April 20, 2026 using q.e.d's public home page, privacy policy, terms, and on-site FAQ language. We did not upload a manuscript to q.e.d for this update.

In our pre-submission review work

In our pre-submission review work comparing q.e.d Science to submission-readiness tools, q.e.d tends to be useful earlier than most buyers first assume. We see it help when the manuscript's reasoning still feels unstable, when co-authors disagree about what the paper actually proves, or when the story is logically thinner than the data volume suggests.

The comparison only makes sense if buyers judge q.e.d against the right alternative: not grammar tools, but other tools that claim to reduce pre-submission risk. Across the manuscripts we screen, three patterns decide whether q.e.d is the right tool or only half of one:

  • Claim-logic gaps q.e.d catches well: an overstated conclusion in the discussion, an inferential jump where the results do not license the claim, or a co-author disagreement about what the abstract actually asserts. This is q.e.d's strongest lane, and it is a real failure mode that a reasoning review surfaces early.
  • Submission risks q.e.d does not cover: it does not verify the references against a live citation database, it does not read the figures panel by panel, and it does not calibrate journal fit or desk-reject risk. A logically tidy paper can still fail at a selective journal for reasons outside its internal logic.
  • Manuscript-rights nuance to read first: q.e.d's public language bars outside AI providers from training on your manuscript, but reserves some internal model-evaluation and analytics rights. For highly sensitive unpublished work, the methods and data-handling terms deserve a close read before upload.

The practical conclusion we reach with authors is that q.e.d and a submission-readiness tool answer different questions. q.e.d Science stress-tests the argument; a readiness review stress-tests the citations, figures, methods, and journal fit. For a paper close to submission, both dimensions matter, and the two are complements rather than substitutes.

We also see where it stops helping: q.e.d is intentionally built around critical thinking and evidence structure, not around final submission triage, so the buyer's job is to match the tool to the manuscript's actual risk.

What q.e.d actually does

q.e.d describes itself as Critical Thinking AI for scientific research, review, and decision-making.

The public home page makes the product focus unusually clear:

  • break a paper into claims
  • expose the underlying logic
  • identify weaknesses and potential solutions
  • compare the research against a broader paper set

That is a different job from grammar correction or broad "AI reviewer" language.

The cleanest way to describe q.e.d is:

q.e.d is a claim-logic and evidence-structure tool for scientific manuscripts.

Quick comparison

Question
q.e.d Science
What it still does not answer
Does the argument follow from the evidence?
Strong
Whether the journal will consider the paper competitive
Are claims overstated relative to the data?
Strong
Whether the references and figures will survive reviewer scrutiny
Is the submission package ready now?
Partial at best
Final go/no-go judgment

1. It has a sharper product identity than most AI-review tools

Many AI tools in this category promise everything at once.

q.e.d is more specific. It centers on:

  • evidence evaluation
  • logic mapping
  • identifying reasoning gaps

That is a real need. Many manuscripts fail not because the data is absent, but because the argument chain from data to conclusion is weak or overstated.

2. The category differentiation is real

If a paper's main problem is:

  • a weak logic chain
  • unsupported inferential jumps
  • a conclusion that does not clearly follow from the evidence

then q.e.d is more relevant than a generic AI writing tool.

3. The platform has visible researcher adoption

The public site says researchers at 1,000+ institutions use q.e.d. That does not prove review quality by itself, but it does suggest the product is getting real attention in the research community.

The main thing to understand before using q.e.d

q.e.d is strong on argument structure.

It is weaker on:

  • live field-specific novelty judgment
  • journal-specific submission expectations
  • reviewer-style strategic advice

This matters because a manuscript can be logically coherent and still fail at a selective journal for reasons outside internal logic.

Where q.e.d sits against submission-readiness tools

Workflow need
q.e.d Science
Submission-readiness tool
Claim-tree reasoning and inferential gaps
Stronger
Weaker
Citation verification and figure analysis
Not available
Stronger
Journal-fit and desk-reject calibration
Limited
Stronger
Named human expert escalation
Not built in
Available on some platforms

Privacy and manuscript-rights nuance

This is where q.e.d deserves more careful reading than most buyers give it.

The public FAQ says:

  • only you and invited collaborators can see the manuscript
  • AI providers are contractually barred from training their foundation models on your data
  • q.e.d will not publish or claim authorship over your work

Those are positive signals.

But the same FAQ and rights language also say:

  • you grant q.e.d a revocable, non-exclusive license to generate feedback
  • the license may also cover training and evaluation of q.e.d's own models
  • anonymized and aggregated analytics may be created

So the right interpretation is not "perfectly no-training." The right interpretation is:

their external AI providers are not supposed to train on your data, but q.e.d reserves some internal model-improvement and analytics rights.

That is not automatically bad. It is just something buyers should read closely, especially for highly sensitive unpublished work.

q.e.d Science Strengths: Where It Is Strong

q.e.d is a good fit if:

  • the draft's argument still feels unstable
  • co-authors keep disagreeing on what the paper actually claims
  • the data are present but the reasoning feels weaker than it should
  • you want a private pre-submission tool with better-than-average transparency

1. It is not a substitute for field judgment

Claim logic is not the same thing as competitive scientific positioning.

q.e.d can help show whether the argument makes sense on its own terms. It cannot reliably tell you whether the field already moved past that claim six months ago.

2. The privacy story is good, but not as simple as the headline suggests

Many users will read "your research is private" and stop there.

The underlying FAQ is more nuanced. If manuscript-rights handling is a major issue for your lab, read the rights and deletion language carefully before uploading.

3. The public site emphasizes access over simple pricing

q.e.d's public pages emphasize getting started and product access, not a classic transparent per-manuscript or self-serve pricing table.

That does not make the product worse, but it makes quick commercial comparison harder.

q.e.d vs Manusights

This is the cleanest distinction:

Question
Better fit
"Is the argument chain in this paper logically strong?"
q.e.d
"Is this paper ready for this journal?"
Manusights

q.e.d is better for logic stress-testing.

Manusights is better for reviewer-style readiness assessment.

For the direct comparison, read Manusights vs q.e.d Science.

Before choosing any service, manuscript readiness check in 1-2 minutes. It scores desk-reject risk for your target journal and identifies top issues - at no cost. The $39 Manusights diagnostic adds citation verification against 500M+ papers (CrossRef, PubMed, arXiv), vision-based figure analysis of every panel, section-by-section scoring (1-5 scale), journal-fit ranking with alternatives, and a prioritized A/B/C experiment fix list.

For career-critical submissions, Manusights expert review ($1,000+) provides a named field-matched scientist with 12-18 specific revision recommendations and cover letter strategy.

Pricing and feature comparison

q.e.d emphasizes product access over a transparent per-manuscript price, which makes a quick commercial comparison harder. Here is how the feature set and pricing line up against the two Manusights tiers most buyers weigh it against.

Feature
q.e.d Science
Manusights $39
Manusights Expert
Primary job
Claim-logic and evidence-structure analysis
Reviewer-style submission readiness
Named human, field-matched review
Pricing model
Access-based, no public per-manuscript price
$39 per manuscript
$1,000+ per manuscript
Citation verification
Not available
Yes, against 500M+ papers
Yes
Figure analysis
Not available
Yes, vision-based per panel
Yes
Journal-fit and desk-reject calibration
Limited
Yes
Yes
Privacy and manuscript-rights
Nuanced (reserves internal model rights)
No-train on your manuscript
No-train on your manuscript

Choose q.e.d if:

  • you want focused feedback on argument structure, claims, and evidence logic
  • the paper's biggest risk is reasoning gaps rather than formatting or language
  • you want a tool that evaluates scientific reasoning, not just grammar or structure

Think twice if:

  • you need journal-specific submission guidance or editorial calibration
  • citation verification and figure analysis are priorities
  • you need a privacy-certified service with zero-retention guarantees
  • you want human expert escalation for career-critical manuscripts
  • your real question is whether the paper should be submitted this month, not whether the claims are logically tidy

Readiness check

Find out what this manuscript actually needs before you choose a service.

Run the free scan to see whether the issue is scientific readiness, journal fit, or citation support before paying for more help.

Diagnose my paperAnthropic Privacy Partner. Zero-retention manuscript processing.See example reports

Alternatives to q.e.d Science

If you are weighing q.e.d against other ways to reduce pre-submission risk, the closest alternatives sit in different lanes:

  • Manusights: reviewer-style submission readiness with citation verification, figure analysis, and journal-fit / desk-reject calibration. Best when the paper is close to submission.
  • Paperpal: language and writing-quality checks with some manuscript-readiness features. Best when the main risk is clarity and English, not reasoning.
  • Penelope: automated technical and structural checks (references, sections, statistics reporting) against journal requirements. Best for a fast formatting and completeness pass.

q.e.d remains the most differentiated of these on pure claim-logic and evidence-structure analysis; the others cover the citations, figures, language, and journal fit that q.e.d does not.

Bottom line

q.e.d is one of the more differentiated AI tools in this market because it is not pretending to be a generic reviewer clone. It is focused on claims, evidence, and reasoning.

That makes it genuinely useful.

But it is still a different category from pre-submission peer-review simulation, and its privacy story is strong but not simplistic. For the right manuscript, q.e.d is a good complement. It is rarely the full answer on its own.

  • Manusights vs q.e.d Science
  • Best pre-submission manuscript review service
  • AI peer review vs human expert review

Before you submit

A manuscript scope and readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.

Last verified against Clarivate JCR 2024 data and official journal author guidelines. Data updates annually with each JCR release.

Frequently asked questions

q.e.d Science is best at claim-logic analysis. It breaks manuscripts into claims, maps the evidence chain, and highlights inferential gaps or overstated conclusions. It is worth using when the paper's main risk is reasoning quality; it is stronger for argument stress-testing than for final submission readiness.

Private by default, but the public rights language is more nuanced than a simple no-training promise. q.e.d says outside AI providers are barred from training on your manuscript, while q.e.d itself reserves some rights for internal model evaluation and anonymized analytics. Sensitive labs should read the privacy and terms pages carefully before uploading.

No. q.e.d focuses on claim structure and evidence logic. It does not verify references against live databases, read figure panels, or score journal-specific submission readiness.

Use q.e.d when the paper's main risk is reasoning quality: weak inferential links, overclaimed conclusions, or co-author disagreement about what the paper actually proves. Use a manuscript review tool when the paper is close to submission and the main risk is citations, figures, journal fit, or reviewer-style judgment.

References

Sources

  1. q.e.d Science home
  2. q.e.d Science privacy policy
  3. q.e.d Science terms of use
  4. q.e.d Science on bioRxiv
  5. q.e.d Science terms of use

Final step

Run the scan before you spend more on editing or external review.

Use the Free Readiness Scan to get a manuscript-specific signal on readiness, fit, figures, and citation risk before choosing the next paid service.

Best for commercial comparison pages where the buyer is still choosing the right help.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Internal navigation

Where to go next